Idarucizumab rapidly reverses the anticoagulant effect of dabigatran | ISTH

Median time to cessation of bleeding in evaluable patients without intracranial bleeding was 2.5 h.
Median time to cessation of bleeding in evaluable patients without intracranial bleeding was 2.5 h.